Asprius Lifesciences, a Gujarat-based pharmaceutical company, has announced the development of a treatment for Diabetic Neuropathy, a condition that causes nerve damage in the body's peripheral areas. The company stated that it has already filed...
The pharmaceutical business has always been at the forefront of technical breakthroughs, trying to better medication development procedures and, eventually, patient results.
Sonali Bendre has been named as FUJIFILM India's brand ambassador for breast cancer screening advocacy. Sonali Bendre's incredible journey of resilience and determination has made her a powerful voice in the fight against cancer,...
As per to Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance, India should try to reach an agreement with Australia to use the Pharmaceutical Benefit Scheme (PBS) for the selection, listing, and pricing of exported medicines. ..
Akums Drugs and Pharmaceuticals Limited's triple combination diabetic treatment has been approved. Sitagliptin 100, Pioglitazone 15, and Metformin 1000/500 are more advanced diabetes treatments with far more efficacy and precision...
Moderna announced the start of patient enrollment in a late-stage study evaluating its tailored mRNA-based skin cancer vaccine in combination with Merck's blockbuster medication Keytruda. A mid-stage research found that the combination...
Pillar Biosciences Inc., the pioneers of Decision Medicine, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced a strategic partnership to make Pillar's suite of oncology assays commercially...
Bharat Serums and Vaccines Limited (BSV), a leading biopharmaceutical business in India, has enlisted the help of Bureau Veritas (India) Limited (BVIL), a global leader in audit and certification services, as part of its ART Act...
Merck India's collaboration with the Department of Atomic Energy's Heavy Water Board will enable the company to produce deuterated compounds for advanced chemistry applications in pharma and biotechnology. According to the company, this will....
Cognizant announced the extension of its partnership with biopharmaceutical firm Gilead Sciences for another five years, including the renewal and expansion of Cognizant's services, for a total projected value of $800 million. The NASDAQ-listed IT...
, CDSCO.jpg)
.jpg)